{"name":"Bial R&D Investments, S.A.","slug":"bial-r-d-investments-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNa1lJR1NLdU8xRHdLMEh1S0ZVdjB6cGZ2czVsLS04ZkNRUm5tckdGRzJDWUwtRVFVeFBWTElyaUxJcTM0OVRHS2F3bkVHcWViQUktWWN4SWZMYXpHMkJfOENVSUVzdXpqVGpYT0Y2aHF5Z1RvVnpGa2JGV0JXaDM1cURzNnFpVkxpM3dkem1faVdEeEZNeldVWjN2V3NvZzlXR1Qxd1hBdUlhNjRIN1ZCTEVnR0pxZ1RRNXhnUk5ha21WNktzRkZkaWxXRGhqUGs3SG9aeUQyUWZyWjVBTGJ5dzVaSms1RzhTM1JwaEFZdGpnUzJrM0VEYV9PRm82Y210a2FRbEJzNlNNemNXenc?oc=5","date":"2025-01-07","type":"trial","source":"PR Newswire UK","summary":"BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease - PR Newswire UK","headline":"BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Dis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQRHpKczIwT01uRjRLeU8xR0Jra3hOZGoyUDd4MHBvb3Npci00dFZPcWRJSTJQT05wTUh6U0Vlbzk0eEZsdGVRekVsdlctMHN5RkxiWEM1VVAteWhzZV9LemRsY1pmT3dCMm9YNWVzc3BhNmZmQjVwS0t3QkVhcElKbGlWS1I5aWJTOTRuX2kwY1NWaEFDRGZfUE4zRDVMeU1kYW1GcVdfMUpfdm8?oc=5","date":"2023-08-14","type":"trial","source":"neurologylive.com","summary":"First Patient Dosed in Phase 2 ACTIVATE Trial of BIA 28-6156 for Parkinson Disease - neurologylive.com","headline":"First Patient Dosed in Phase 2 ACTIVATE Trial of BIA 28-6156 for Parkinson Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxOQnJjYzl3MURkeEx4c0M3RnEyREQ0QkhHYkVZZk9YV2xLd1ZNN2hkSnEzU0pFNTNDQTFmTG1ZZnlWdTl5Y21SX29wRkdEUHBaSVNZSEVERWt2ZXVNZkR2cjFITnBYY05adEtpcmY3ZzlOQWRWcF82cG9kZ0JYazFvMC1Ed0VKMnh3ZEFsREZSZVlkcEZhTjRTeFVEa0tMTEEyYnZuMXo1V3U0aWkzQVJWSklWUkdpanFSWFdUdE5TcUpLZ3BBclZRM2diR0pUYWt1OWlnUlpNM0R1V2JqZ21zU0JPcHlKN255aW9naWxxcDVKdWpNQ1BUaVdwZXpUQTl3Y2VoS0d0MEJKUkRaQU4wSXNfV1BlN3Z5MVVHREh5SWc1c2RySWIydXdlM0lIc3VrWUdId1NjZEx4bzFs?oc=5","date":"2023-05-25","type":"trial","source":"BioSpace","summary":"BIAL R&D Announces First Patient Dosed in its Phase 2 Clinical Trial of BIA 28-6156 to Treat Parkinson's Disease Patients With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene - BioSpace","headline":"BIAL R&D Announces First Patient Dosed in its Phase 2 Clinical Trial of BIA 28-6156 to Treat Parkinson's Disease Patient","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}